Updates in Infectious Disease 2025 – Part 2 Date: Tue, Jan 28th, 2025 Time: 8:00 am - 9:00 am Location: Online
Speakers:
Carl M. Urban, Ph.D.
Associate Professor of Microbiology in Clinical Medicine
Weill Cornell Medicine
Director, Infectious Disease Research Laboratory, NYPQ
James Truong, Pharm.D.
Clinical Pharmacy Manager
Division of Infectious Disease, NYPQ
Lok Yung, M.D.
Attending Physician
Division of Infectious Disease, NYPQ
Disclosures: Dr. Urban is a Advisor for Pfizer. Dr. Yung and Dr. Truong have no financial relationships with ineligible companies.
All relevant relationships have been mitigated.
> Explain the use of Doxycycline postexposure prophylaxis for bacterial sexually transmitted infection prevention.
> Provide a comprehensive sexual health approach for bacterial sexually transmitted infection.
> Recognize the arsenal of antibiotic resistance mechanisms (innate or acquired) associated with Acinetobacter.
> Review current antibacterials approved with activity against MDR Acinetobacter.
> Understand the activity and resistance mechanisms of current beta-lactam antibacterials active against MDR Acinetobacter.
> Understand why combination therapy may be required for infections caused by multidrug resistant MDR Acinetobacter.
> Summarize organisms and mechanisms of antimicrobial resistance that can be detected using BioFire® BCID2.
> Interpret BCID2 results on EPIC and learn how to avoid common "pitfall views".
> Identify where to access treatment guidelines for BCID2.
Accreditation
NewYork Presbyterian/Queens is accredited by the Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians.
NewYork Presbyterian/Queens designates this Live Activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement
The Medical Society of The State of New York relies upon planners and faculty participants in its CME activities to provide educational information that is objective and free of bias. In this spirit and in accordance with the guidelines of MSSNY, CPME and the ACCME, all speakers and planners for CME activities must disclose any relevant financial relationships with
commercial interests whose products, devices or services may be discussed in the content of a CME activity, that might be perceived as a real or apparent conflict of interest. Any discussion of investigational or unlabeled uses of a product will be identified.